Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRILACICLIB vs TRIPTORELIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRILACICLIB vs TRIPTORELIN: Safety Overview

Metric TRILACICLIB TRIPTORELIN
Total FAERS Reports 226 5,379
Deaths Reported 29 528
Death Rate 12.8% 9.8%
Hospitalizations 96 1,315
Average Patient Age 62.2 yrs 48.3 yrs
% Female Patients 43.9% 50.1%
FDA Approval Date Feb 12, 2021 Jun 15, 2000
Manufacturer Pharmacosmos Therapeutics Inc. Azurity Pharmaceuticals, Inc.
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription